Radiotherapy (RT) is a mainstay of treatment for Head and Neck cancers (H&N-C), offered to nearly 75 percent of all H&N-C patients with either curative or palliative intent1. For many primary sites within the H&N, RT yields better…
Introduction Treatments for Head and Neck cancer (H&N-C) are often complex and burdensome, involving a 6- to 7- week radiotherapy (RT) regimen that may be augmented by concurrent chemotherapy1. Receiving RT can cause discomfort and anxiety to…
Introduction: The increase in cancer incidence and mortality calls for a search of effective methods to improve patient's quality of life and well-being. Aim: The aim of this article is to present a case study that examined the application of eye…
